We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cancer Diagnostics – Products

The Certis logo
Product News

Certis Oncology Solutions Announces Three Abstracts Accepted for Presentation at AACR Annual Meeting

Certis Oncology Solutions has announced that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting.
The Personalis logo
Product News

Personalis Joins Top UK Cancer Research Organizations To Evaluate Earlier Cancer Recurrence Detection

Personalis, Inc., Cancer Research UK’s Cancer Research Horizons, University College London and the Francis Crick Institute have announced a collaboration to deploy a personalized liquid biopsy-based research assay, for the TRACERx study.
The owlstone medical logo.
Product News

Owlstone Medical Enters Partnership To Develop Probes for Early Cancer Detection

Owlstone Medical has announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.
Fully Automated Image-Based Single-Cell Isolation and Picking content piece image
App Note / Case Study

Fully Automated Image-Based Single-Cell Isolation and Picking

Download this app note to learn how you can select 20 individual CTCs in 10 minutes, this approach can be used for DNA, RNA or proteome analysis as well as how these target cells are selected and isolated in high purity from heterogenous backgrounds.
The Personalis logo
Product News

Personalis Selected for Clinical Research After Successful Evaluation of Residual Disease Assay

Personalis, Inc. has announced it will continue its collaboration with AstraZeneca to explore ultra-sensitive molecular residual disease measurement, including clinically relevant and personalized variant tracking, for clinical research and drug development.
Optimizing the Isolation of Cell-Free DNA From Liquid Biopsy Samples content piece image

Optimizing the Isolation of Cell-Free DNA From Liquid Biopsy Samples

Diagnostic tests are at the core of medicine. Liquid biopsies in particular are incredibly valuable, giving a more holistic disease profile and making it easier to measure a condition over time.
The Biomek NGeniuS Next Generation Library Prep System
Product News

Beckman Coulter Life Sciences Presenting at SLAS2023

Beckman Coulter Life Sciences will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening International Conference and Exhibition.
Two hands holding jigsaw pieces representing a partnership.
Product News

Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
Investigating Cell-Free DNA in Liquid Biopsy content piece image

Investigating Cell-Free DNA in Liquid Biopsy

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.
The QuantStudio Absolute Q dPCR System
Product News

New dPCR Liquid Biopsy Assays for QuantStudio Absolute Q dPCR System and Custom Design Tool Simplify Cancer Research

Thermo Fisher Scientific has introduced over 50 new Absolute Q Liquid Biopsy Assays to run on the Applied Biosystems QuantStudio Absolute Q dPCR System.